Literature DB >> 10827454

RTK mutations and human syndromeswhen good receptors turn bad.

S C Robertson1, J A Tynan, D J Donoghue.   

Abstract

Mutations in receptor tyrosine kinases (RTKs) have been linked to an increasing number of inherited human disease syndromes, including dwarfism, craniosynostosis, heritable cancer susceptibility, venous malformation and Piebaldism. Both gain-of-function mutations resulting in constitutive receptor activation, and loss-of-function mutations resulting in non-functional or dominant negative receptors, have been observed. This review summarizes RTK families that are involved in inherited syndromes, describes the molecular consequences of the disease mutations, and predicts that many novel mutations remain to be identified.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827454     DOI: 10.1016/s0168-9525(00)02021-7

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  35 in total

1.  Receptor-like kinases from Arabidopsis form a monophyletic gene family related to animal receptor kinases.

Authors:  S H Shiu; A B Bleecker
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

Review 2.  Structural and evolutionary relationships among protein tyrosine phosphatase domains.

Authors:  J N Andersen; O H Mortensen; G H Peters; P G Drake; L F Iversen; O H Olsen; P G Jansen; H S Andersen; N K Tonks; N P Møller
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 3.  Single-spanning transmembrane domains in cell growth and cell-cell interactions: More than meets the eye?

Authors:  Pierre Hubert; Paul Sawma; Jean-Pierre Duneau; Jonathan Khao; Jérôme Hénin; Dominique Bagnard; James Sturgis
Journal:  Cell Adh Migr       Date:  2010-04-20       Impact factor: 3.405

4.  Identification and characterization of DAlk: a novel Drosophila melanogaster RTK which drives ERK activation in vivo.

Authors:  C E Lorén; A Scully; C Grabbe; P T Edeen; J Thomas; M McKeown; T Hunter; R H Palmer
Journal:  Genes Cells       Date:  2001-06       Impact factor: 1.891

Review 5.  Clinical significance of FLT3 in leukemia.

Authors:  Hitoshi Kiyoi; Masamitsu Yanada; Kazutaka Ozekia
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

Review 6.  Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies.

Authors:  Edwin Li; Kalina Hristova
Journal:  Biochemistry       Date:  2006-05-23       Impact factor: 3.162

7.  Leucine motif-dependent tyrosine autophosphorylation of type III receptor tyrosine kinases.

Authors:  Rosana D Meyer; Xiaofeng Qian; Hwai-Chen Guo; Nader Rahimi
Journal:  J Biol Chem       Date:  2006-01-23       Impact factor: 5.157

Review 8.  microRNA: a promising diagnostic biomarker and therapeutic target for hepatocellular carcinoma.

Authors:  Xiaofei Li; Wenjun Yang; Lianqing Lou; Yongxin Chen; Shuang Wu; Guoqiang Ding
Journal:  Dig Dis Sci       Date:  2014-01-04       Impact factor: 3.199

9.  Nordihydroguaiaretic acid inhibits an activated fibroblast growth factor receptor 3 mutant and blocks downstream signaling in multiple myeloma cells.

Authors:  April N Meyer; Christopher W McAndrew; Daniel J Donoghue
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

10.  The effect of hydrophilic substitutions and anionic lipids upon the transverse positioning of the transmembrane helix of the ErbB2 (neu) protein incorporated into model membrane vesicles.

Authors:  Khurshida Shahidullah; Shyam S Krishnakumar; Erwin London
Journal:  J Mol Biol       Date:  2009-11-18       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.